New shot offers hope for teens with severe eczema
NCT ID NCT07042126
Summary
This study is testing an experimental drug called 611 for teenagers with moderate-to-severe atopic dermatitis (eczema). It aims to see if the drug, given as an injection, can significantly clear skin and reduce itching compared to a placebo. The trial will involve 180 Chinese adolescents aged 12-17 over a 64-week period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
RECRUITINGNanchang, Zhejiang, 310003, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Fourth Affiliated Hospital Zhejiang University School of Medicine
RECRUITINGJinhua, Zhejiang, 322000, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.